Roche steps into point-of-care molecular diagnostics with IQuum buy
This article was originally published in Clinica
Executive Summary
IVD market leader Roche has entered the point-of-care molecular diagnostics sector, acquiring IQuum for $275m upfront and up to $175m in milestones.